Coronavirus Update: Synairgen Tests First Inhaled Candidate, No New China Cases
While Survey Shows Looming Crisis In Trial Recruitment
Executive Summary
More studies are being launched into possible treatments for patients hospitalised with COVID-19, with Roche launching a Phase III, placebo-controlled trial of Actemra.